510(k) K212057
K212057 is an FDA 510(k) premarket notification submitted by Artventive Medical Group, Inc. for the device "Endoluminal Occlusion System, EOS-X, Endoluminal Occlusion System, EOS". The FDA issued a decision of Substantially Equivalent on Mar 1, 2022. The device falls under product code KRD (Device, Vascular, For Promoting Embolization), a Class II device regulated under 21 CFR 870.3300. Artventive Medical Group, Inc. has 2 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Mar 1, 2022
- Date Received
- Jul 1, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Device, Vascular, For Promoting Embolization
- Device Class
- Class II
- Regulation Number
- 870.3300
- Review Panel
- CV
- Submission Type
- 510(k)